These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Deoxyadenosine triphosphate as a potentially toxic metabolite in adenosine deaminase deficiency. Cohen A; Hirschhorn R; Horowitz SD; Rubinstein A; Polmar SH; Hong R; Martin DW Proc Natl Acad Sci U S A; 1978 Jan; 75(1):472-6. PubMed ID: 272665 [TBL] [Abstract][Full Text] [Related]
6. Reciprocal relationship between erythrocyte ATP and deoxy-ATP levels in inherited ADA deficiency. Simmonds HA; Levinsky RJ; Perrett D; Webster DR Biochem Pharmacol; 1982 Mar; 31(6):947-51. PubMed ID: 7082375 [TBL] [Abstract][Full Text] [Related]
7. Deoxyadenosine triphosphate accumulation in erythrocytes of deoxycoformycin-treated mice. Smith CM; Henderson JF Biochem Pharmacol; 1982 Apr; 31(8):1545-51. PubMed ID: 6980005 [TBL] [Abstract][Full Text] [Related]
8. Role of glycolysis in deoxyadenosine induced ATP depletion and dATP accumulation in red cells. Koller CA; Orringer EP; Berkowitz LR; Mulhern AT Prog Clin Biol Res; 1984; 165():227-39. PubMed ID: 6334314 [No Abstract] [Full Text] [Related]
9. Comparison of red cell transfusion and polyethylene glycol-modified adenosine deaminase therapy in an adenosine deaminase-deficient child: measurement of erythrocyte deoxyadenosine triphosphate as a useful tool. Bory C; Boulieu R; Souillet G; Chantin C; Rolland MO; Mathieu M; Hershfield M Pediatr Res; 1990 Aug; 28(2):127-30. PubMed ID: 2395602 [TBL] [Abstract][Full Text] [Related]
10. B-lymphocytes, thymocytes and platelets accumulate high dATP levels in simulated ADA deficiency. Goday A; Simmonds HA; Fairbanks LD; Morris GS Adv Exp Med Biol; 1986; 195 Pt A():515-20. PubMed ID: 3487922 [No Abstract] [Full Text] [Related]
15. Effect of red cell transfusions, thymic hormone and deoxycytidine in severe combined immunodeficiency due to adenosine deaminase deficiency. Davies EG; Levinsky RJ; Webster DR; Simmonds HA; Perrett D Clin Exp Immunol; 1982 Nov; 50(2):303-10. PubMed ID: 6983936 [TBL] [Abstract][Full Text] [Related]
16. Metabolic abnormalities of human adenosine deaminase deficiency reproduced in the mouse by 2'-deoxycoformycin, and adenosine deaminase inhibitor. Ratech H; Thorbecke GJ; Hirschhorn R Clin Immunol Immunopathol; 1981 Oct; 21(1):119-27. PubMed ID: 6268339 [No Abstract] [Full Text] [Related]
17. Enzyme activities of leukemic cells and biochemical changes induced by deoxycoformycin in vitro--lack of correlation with clinical response. Ho AD; Ganeshaguru K; Knauf W; Dietz G; Trede I; Hoffbrand AV; Hunstein W Leuk Res; 1989; 13(4):269-78. PubMed ID: 2785618 [TBL] [Abstract][Full Text] [Related]
18. Plasma deoxyadenosine, adenosine, and erythrocyte deoxyATP are elevated at birth in an adenosine deaminase-deficient child. Hirschhorn R; Roegner V; Rubinstein A; Papageorgiou P J Clin Invest; 1980 Mar; 65(3):768-71. PubMed ID: 6965496 [TBL] [Abstract][Full Text] [Related]
19. Heterogeneity of biochemical, clinical and immunological parameters in severe combined immunodeficiency due to adenosine deaminase deficiency. Morgan G; Levinsky RJ; Hugh-Jones K; Fairbanks LD; Morris GS; Simmonds HA Clin Exp Immunol; 1987 Dec; 70(3):491-9. PubMed ID: 3436096 [TBL] [Abstract][Full Text] [Related]
20. Mechanism of adenosine triphosphate catabolism induced by deoxyadenosine and by nucleoside analogues in adenosine deaminase-inhibited human erythrocytes. Bontemps F; Van den Berghe G Cancer Res; 1989 Sep; 49(18):4983-9. PubMed ID: 2788493 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]